𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A meeting of minds: Overcoming roadblocks in the development of therapies for neurodegenerative disorders

✍ Scribed by Miratul M. K. Muqit; Dario R. Alessi


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
108 KB
Volume
1
Category
Article
ISSN
1757-4676

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Development of a competitive exclusion p
✍ Viviana Klose; Michaela Mohnl; Regina Plail; Gerd Schatzmayr; Andreas-Paul Loibn πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 701 KB

## Abstract Competitive exclusion treatment is able to increase the pathogen colonization resistance of day‐old chicks by applying probiotic bacteria stabilizing the indigenous microflora. In order to develop a safe microbial feed additive, various bacterial strains were isolated out of the gastroi

Gene-directed enzyme prodrug therapy for
✍ Rosetta Martiniello-Wilks; Allison Dane; Dale J. Voeks; Geetha Jeyakumar; Elin M πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 310 KB πŸ‘ 1 views

## Abstract ## Background Gene‐directed enzyme prodrug therapy (GDEPT) based on the __E. coli__ enzyme purine nucleoside phosphorylase (PNP) represents a new approach for treating slow growing tumours like prostate cancer (PCa). Expressed enzyme converts a systemically administered prodrug, fludar

Functional analysis of three splicing mu
✍ Ana I. Vega; Celia PΓ©rez-CerdΓ‘; Lourdes R. Desviat; Gert Matthijs; Magdalena Uga πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 314 KB

The congenital disorders of glycosylation (CDG) are a group of diseases caused by genetic defects affecting N-glycosylation. The most prevalent form of CDG-type Ia-is caused by defects in the PMM2 gene. This work reports the study of two new nucleotide changes (c.256-1G>C and c.640-9T>G) identified